Projects funded by the NCN
PIM kinases as rational therapeutic targets in lymphoid malignancies.
2011/03/B/NZ4/02020
Keywords:
oncogenesis kinases targeted therapies biomarkers
Descriptors:
- NZ4_5: Anatomical pathology
- NZ1_11: Other related subjects
- NZ2_11: Genetic epidemiology
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
dr hab. Przemysław Juszczyński
Number of co-investigators in the project: 3
Call: OPUS 2 - announced on 2011-09-15
Amount awarded: 781 500 PLN
Project start date (Y-m-d): 2012-12-21
Project end date (Y-m-d): 2015-06-20
Project duration:: 30 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (2)
- Expression of PIM Kinases in Reed-Sternberg Cells Fosters Immune Privilege and Tumor Cell Survival in Classical Hodgkin LymphomaAuthors:Maciej Szydłowski, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz, Grażyna Hoser, Ewa Jabłońska, Emilia Białopiotrowicz, Przemysław Kiliszek, Tomasz Sewastianik, Anna Polak, Wojciech Czardybon, Michał Gałęzowski, Renata Windak, Krzysztof Brzózka, Jan Maciej Zaucha, Krzysztof Warzocha, Przemysław JuszczyńskiAcademic press:Blood (rok: 2017, tom: n/a, strony: n/a), Wydawca: American Society of HematologyStatus:PublishedDOI:10.1182/blood-2017-01-760702 - link to the publication
- Kinazy PIM jako cel terapeutyczny w nowotworach układów krwiotwórczego i chłonnegoAuthors:P. JuszczyńskiAcademic press:Hematologia (rok: 2014, tom: 5, strony: 305–316), Wydawca: Via MedicaStatus:PublishedDOI:brak - link to the publication